Achieving GSPR Compliance Under EU MDR 2017/745: A Comprehensive Guide

The European Medical Device Regulation (EU MDR 2017/745) has significantly transformed the regulatory landscape for medical devices in the European Union. A central component of this framework is the General Safety and Performance Requirements (GSPR) outlined in Annex I, which establishes stringent benchmarks for device safety, performance, and risk management.

Achieving GSPR compliance is mandatory for obtaining CE marking, enabling manufacturers to legally market medical devices in the EU. With increased scrutiny, expanded clinical evidence requirements, and continuous post-market obligations, organizations must adopt a strategic, data-driven compliance approach.

Understanding GSPR Under EU MDR 2017/745

GSPR replaces the Essential Requirements (ERs) from the previous Medical Device Directive (MDD) and introduces a more robust, lifecycle-based compliance model.

Core Structure of GSPR (Annex I)

Each requirement must be supported by objective evidence documented within the Technical File or Design Dossier.

Step-by-Step Approach to Achieve GSPR Compliance

1. Step 1: Conduct a Comprehensive Gap Analysis

A detailed EU MDR gap assessment identifies compliance gaps between existing documentation and MDR expectations.

Key Activities:

• Mapping legacy MDD documentation to MDR Annex I 
• Identifying missing test data and clinical evidence 
• Evaluating labeling, IFU, and UDI compliance 

2. Step 2: Develop a Structured GSPR Checklist

A GSPR checklist is a critical compliance tool that ensures traceability and audit readiness.

GSPR Checklist Structure

3. Step 3: Implement Risk Management (ISO 14971:2019)

Risk management is the backbone of MDR compliance and must follow ISO 14971:2019.

Process Includes:

• Hazard identification (biological, mechanical, electrical) 
• Risk estimation and evaluation 
• Risk control implementation 
• Benefit-risk analysis 

4. Step 4: Ensure Biocompatibility & Chemical Safety (ISO 10993)

Compliance with ISO 10993 standards is essential for evaluating biological safety.

Key Considerations:

• Cytotoxicity, sensitization, irritation testing 
• Extractables and leachables analysis 
• Toxicological risk assessments 

5. Step 5: Conduct Clinical Evaluation (CER)

The Clinical Evaluation Report (CER) must align with MEDDEV 2.7/1 Rev. 4 and MDR requirements.

Clinical Evaluation Components

6. Step 6: Strengthen Post-Market Surveillance (PMS) & Vigilance

MDR emphasizes continuous lifecycle monitoring.

Requirements Include:

• PMS Plan & PMS Report 
• Periodic Safety Update Report (PSUR) 
• Trend reporting & vigilance system 
• Post-Market Clinical Follow-up (PMCF) 

7. Step 7: Compile Technical Documentation

A complete Technical File / Design Dossier must include:

• GSPR Checklist 
• Risk Management File 
• Clinical Evaluation Report (CER) 
• Biocompatibility Reports 
• Labeling & IFU Compliance 
• PMS & Vigilance Documentation 

Key Challenges in GSPR Compliance

Best Practices for Streamlined GSPR Compliance

• Develop a proactive MDR regulatory strategy 
• Maintain a living GSPR checklist with traceability matrix
• Integrate risk management and usability engineering (IEC 62366) 
• Align with latest MDCG guidance documents (2024–2026 updates) 
• Implement digital documentation systems for audit readiness
• Ensure UDI (Unique Device Identification) compliance 

Latest Regulatory Updates & Trends

• Increased focus on Post-Market Clinical Follow-up (PMCF)
• Enhanced scrutiny on Software as a Medical Device (SaMD)
• Adoption of EUDAMED database for transparency 
• Stricter Notified Body review processes 
• Integration of AI/ML in medical device compliance validation

How Maven Regulatory Solutions Supports GSPR Compliance

Maven Regulatory Solutions provides end-to-end expertise in EU MDR compliance and GSPR implementation.

Our Core Services

• EU MDR Gap Analysis & Compliance Strategy 
• GSPR Checklist Development & Technical Documentation 
• ISO 14971 Risk Management & ISO 10993 Biocompatibility 
• Clinical Evaluation Report (CER) Authoring 
• PMS, PMCF & PSUR Implementation 
• Regulatory Submission & CE Marking Support 

With deep expertise in global medical device regulations, Maven ensures efficient, compliant, and audit-ready submissions.

Conclusion

Achieving GSPR compliance under EU MDR 2017/745 is a complex yet essential requirement for medical device manufacturers targeting the European market. By adopting a structured compliance framework, leveraging risk-based methodologies, and ensuring continuous post-market monitoring, organizations can successfully obtain CE marking and sustain long-term regulatory compliance.

Maven Regulatory Solutions empowers manufacturers with specialized regulatory expertise, technical documentation support, and compliance strategies, ensuring a seamless path to EU market access.

Frequently Asked Questions 

1. What is GSPR in EU MDR?

GSPR refers to General Safety and Performance Requirements outlined in Annex I of EU MDR 2017/745, ensuring device safety and effectiveness.

2. Why is GSPR compliance important?

It is mandatory for obtaining CE marking and ensuring legal market access in the EU.

3. What is included in the GSPR checklist?

It includes applicable clauses, compliance methods, and supporting documentation references.

4. Which standards support GSPR compliance?

Key standards include ISO 14971, ISO 10993, IEC 62366, and MEDDEV 2.7/1 Rev. 4.

5. How does Maven support EU MDR compliance?

Maven provides end-to-end regulatory consulting, documentation, CER development, and PMS support.